First - line, non - cryopreserved autologous stem cell transplant for poor - risk germ - cell tumors: Experience in a developing country
收藏Figshare2019-01-01 更新2026-04-29 收录
下载链接：
https://figshare.com/articles/dataset/First_-_line_non_-_cryopreserved_autologous_stem_cell_transplant_for_poor_-_risk_germ_-_cell_tumors_Experience_in_a_developing_country/7898525
下载链接
链接失效反馈官方服务：
资源简介：
ABSTRACT Purpose: The current first - line treatment for non - seminomatous germ cell tumor (NSGCT) consists of four cycles of cisplatin, etoposide, and bleomycin (BEP), which results in 5 - year overall survival
创建时间：
2019-01-01
